Callan Capital’s Qiagen QGEN Stock Holding History

Callan Capital’s Portfolio QGEN Stock Details QGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-6,212	Closed	-$285K	–	386
2024 Q4	$285K	Buy	6,212 +973	+19%	+$43.6K	0.02%	263
2024 Q3	$246K	Buy	+5,239	New	+$239K	0.02%	296

Other funds holding QGEN

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Amundi Paris, France $416B AUM 44.19% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Callan Capital's QGEN Position: Q1 2025 in Review

Callan Capital sold out of Qiagen (QGEN) in Q1 2025, closing a stake of 6,212 shares — an estimated $285K sold.

Callan Capital first reported a position in QGEN in Q3 2024 and held it in 2 quarters. The position peaked at $285K in Q4 2024. 299 funds tracked by Wall St. Rank hold QGEN as of Q1 2025.

Callan Capital reported no remaining Qiagen position as of Q1 2025 after selling out during the quarter.
Callan Capital sold 6,212 Qiagen shares in Q1 2025, an estimated $285K.
Callan Capital first reported a position in Qiagen in Q3 2024 and held it in 2 quarters.
Callan Capital's Qiagen position peaked at $285K in Q4 2024.
299 funds tracked by Wall St. Rank held Qiagen as of Q1 2025.

Based on Callan Capital's 13F filing for Q1 2025, filed 29 Apr 2025.